The report will be delivered in 2-3 business days.

Dermatology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Starting Price : $5000 | Pages : 300 | Published : December 2020 | SKU CODE : r376 | Format :


The dermatology drugs market consists of sales of dermatology drugs by entities (organizations, sole traders and partnerships) that produce dermatology drugs to treat skin diseases. This industry includes establishments that produce drugs to treat diseases such as rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections and other skin disorders. The dermatology market is segmented into acne; dermatitis; psoriasis; and other drugs for dermatology diseases.

The global dermatology drugs market is expected to grow from $37.57 billion in 2020 to $40.49 billion in 2021 at a compound annual growth rate (CAGR) of 7.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $62.83 billion in 2025 at a CAGR of 12%.

Asia Pacific was the largest region in the global dermatology drugs market, accounting for 36% of the market in 2020. North America was the second largest region, accounting for 27% of the global dermatology drugs market. Africa was the smallest region in the global dermatology drugs market.

The dermatology drugs market was mainly driven by rapid growth in emerging markets in the historic period. Emerging markets growth was aided by rising disposable income, stable political environment and increasing foreign investments in these countries. For instance, according to the IMF, China’s GDP grew from $11 trillion in 2015 to $13.6 trillion in 2018. Additionally, according to the World Economic Outlook Reports by the IMF, emerging markets and developing economies together registered a growth of 4.0% in 2015 and this increased to 4.5% in 2018. Thus, strong economic growth boosted the demand for dermatology drugs and this drove the market during the historic period.

High costs associated with drugs is a major issue faced by citizens of many countries. Pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, the pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of dermatology drugs manufacturers.

Drug manufacturing companies are using genome testing (genetic diagnosis) to reduce the time and costs spent in clinical trials. A clinical trial is a complex process and it often takes months for a drug to be available in the market. This deprives patients of cost-effective treatment. Researchers in the Rockefeller University used genomic testing and data analytics to predict the response of psoriasis patients for a given treatment. Genomic testing algorithms collect gene-expression data from skin biopsies and detect activity in 50,000 different genes. This technique can predict the response of a patient with an accuracy of 95% and within 12 weeks, thus saving significant time for clinical trials and the launch of new drugs.

The major players covered in the global dermatology drugs market are Johnson & Johnson, Allergan Plc, Galderma S.A, Novartis AG, GlaxoSmithKline Plc.

The countries covered in the global dermatology drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global dermatology drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global dermatology drugs market is segmented -

1) By Type: Acne, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route Of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Dermatology Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Dermatology Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Dermatology Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Dermatology Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Dermatology Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Dermatology Drugs

    9. Dermatology Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Dermatology Drugs Market Regional Analysis

    10.1. Global Dermatology Drugs Market, 2020, By Region, Value ($ Billion)

    10.2. Global Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    10.3. Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region

    11. Dermatology Drugs Market Segmentation

    11.1. Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Acne

    Dermatitis

    Psoriasis

    Other Drugs for Dermatology Diseases

    11.2. Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Dermatology Drugs Market Metrics

    12.1. Dermatology Drugs Market Size, Percentage Of GDP, 2015-2025, Global

    12.2. Per Capita Average Dermatology Drugs Market Expenditure, 2015-2025, Global

    13. Asia-Pacific Dermatology Drugs Market

    13.1. Asia-Pacific Dermatology Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Dermatology Drugs Market Metrics

    13.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Asia-Pacific Countries

    13.6. Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7. Asia-Pacific Dermatology Drugs Market: Country Analysis

    13.7.1. China Dermatology Drugs Market

    13.7.1.1. China Dermatology Drugs Market Overview

    13.7.1.2. China Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.1.3. China Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2. Australia Dermatology Drugs Market

    13.7.2.1. Australia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2.2. Australia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.3. Hong Kong Dermatology Drugs Market

    13.7.3.1. Hong Kong Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4. India Dermatology Drugs Market

    13.7.4.1. India Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4.2. India Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5. Indonesia Dermatology Drugs Market

    13.7.5.1. Indonesia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5.2. Indonesia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6. Japan Dermatology Drugs Market

    13.7.6.1. Japan Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6.2. Japan Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.7. Malaysia Dermatology Drugs Market

    13.7.7.1. Malaysia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.8. New Zealand Dermatology Drugs Market

    13.7.8.1. New Zealand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.9. Philippines Dermatology Drugs Market

    13.7.9.1. Philippines Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.10. Singapore Dermatology Drugs Market

    13.7.10.1. Singapore Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11. South Korea Dermatology Drugs Market

    13.7.11.1. South Korea Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11.2. South Korea Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.12. Thailand Dermatology Drugs Market

    13.7.12.1. Thailand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.13. Vietnam Dermatology Drugs Market

    13.7.13.1. Vietnam Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14. Western Europe Dermatology Drugs Market

    14.1. Western Europe Dermatology Drugs Market Overview

    14.2. Western Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    14.3. Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    14.4. Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Dermatology Drugs Market Metrics

    14.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Western Europe Countries

    14.6. Western Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7. Western Europe Dermatology Drugs Market: Country Analysis

    14.7.1. Austria Dermatology Drugs Market

    14.7.1.1. Austria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.2. Belgium Dermatology Drugs Market

    14.7.2.1. Belgium Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.3. Denmark Dermatology Drugs Market

    14.7.3.1. Denmark Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.4. Finland Dermatology Drugs Market

    14.7.4.1. Finland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5. France Dermatology Drugs Market

    14.7.5.1. France Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5.2. France Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6. Germany Dermatology Drugs Market

    14.7.6.1. Germany Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6.2. Germany Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.7. Ireland Dermatology Drugs Market

    14.7.7.1. Ireland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.8. Italy Dermatology Drugs Market

    14.7.8.1. Italy Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.9. Netherlands Dermatology Drugs Market

    14.7.9.1. Netherlands Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.10. Norway Dermatology Drugs Market

    14.7.10.1. Norway Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.11. Portugal Dermatology Drugs Market

    14.7.11.1. Portugal Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.12. Spain Dermatology Drugs Market

    14.7.12.1. Spain Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.13. Sweden Dermatology Drugs Market

    14.7.13.1. Sweden Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.14. Switzerland Dermatology Drugs Market

    14.7.14.1. Switzerland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15. UK Dermatology Drugs Market

    14.7.15.1. UK Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15.2. UK Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15. Eastern Europe Dermatology Drugs Market

    15.1. Eastern Europe Dermatology Drugs Market Overview

    15.2. Eastern Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    15.3. Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    15.4. Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Dermatology Drugs Market Metrics

    15.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Eastern Europe Countries

    15.6. Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7. Eastern Europe Dermatology Drugs Market: Country Analysis

    15.7.1. Czech Republic Dermatology Drugs Market,  

    15.7.1.1. Czech Republic Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.2. Poland Dermatology Drugs Market

    15.7.2.1. Poland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.3. Romania Dermatology Drugs Market

    15.7.3.1. Romania Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4. Russia Dermatology Drugs Market

    15.7.4.1. Russia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4.2. Russia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16. North America Dermatology Drugs Market

    16.1. North America Dermatology Drugs Market Overview

    16.2. North America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    16.3. North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    16.4. North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. North America, Dermatology Drugs Market Metrics

    16.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, North America Countries

    16.6. North America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7. North America Dermatology Drugs Market: Country Analysis

    16.7.1. Canada Dermatology Drugs Market

    16.7.1.1. Canada Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.2. Mexico Dermatology Drugs Market

    16.7.2.1. Mexico Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3. USA Dermatology Drugs Market

    16.7.3.1. USA Dermatology Drugs Market Overview

    16.7.3.2. USA Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3.3. USA Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17. South America Dermatology Drugs Market

    17.1. South America Dermatology Drugs Market Overview

    17.2. South America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    17.3. South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    17.4. South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. South America, Dermatology Drugs Market Metrics

    17.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, South America Countries

    17.6. South America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7. South America Dermatology Drugs Market: Country Analysis

    17.7.1. Argentina Dermatology Drugs Market

    17.7.1.1. Argentina Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2. Brazil Dermatology Drugs Market

    17.7.1.1. Brazil Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2.2. Brazil Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.3. Chile Dermatology Drugs Market

    17.7.3.1. Chile Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.4. Colombia Dermatology Drugs Market

    17.7.4.1. Colombia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.5. Peru Dermatology Drugs Market

    17.7.5.1. Peru Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.6. Venezuela Dermatology Drugs Market

    17.7.6.1. Venezuela Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18. Middle East Dermatology Drugs Market

    18.1. Middle East Dermatology Drugs Market Overview

    18.2. Middle East, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    18.3. Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    18.4. Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Dermatology Drugs Market Metrics

    18.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Middle East Countries

    18.6. Middle East Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7. Middle East Dermatology Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Dermatology Drugs Market

    18.7.1.1. Saudi Arabia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.2. Israel Dermatology Drugs Market

    18.7.2.1. Israel Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.3. Turkey Dermatology Drugs Market

    18.7.3.1. Turkey Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.4. UAE Dermatology Drugs Market

    18.7.4.1. UAE Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19. Africa Dermatology Drugs Market

    19.1. Africa Dermatology Drugs Market Overview

    19.2. Africa, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)

    19.3. Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    19.4. Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    19.5. Africa, Dermatology Drugs Market Metrics

    19.5.1. Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Africa Countries

    19.6. Africa Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7. Africa Dermatology Drugs Market: Country Analysis

    19.7.1. Egypt Dermatology Drugs Market

    19.7.1.1. Egypt Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.2. Nigeria Dermatology Drugs Market

    19.7.2.1. Nigeria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.3. South Africa Dermatology Drugs Market

    19.7.3.1. South Africa Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20. Dermatology Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Johnson & Johnson

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. Allergan Plc

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Galderma S.A

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Novartis AG

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. GlaxoSmithKline Plc

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Dermatology Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Dermatology Drugs Market In 2025- Growth Countries

    23.2. Global Dermatology Drugs Market In 2025- Growth Segments

    23.3. Global Dermatology Drugs Market In 2025- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Dermatology Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 4: Global Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Dermatology Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Table 12: Per Capita Average Dermatology Drugs Market Expenditure, 2015-2025, Global
  • Table 13: Asia-Pacific, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Table 17: Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 18: China Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 19: China Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 20: Australia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 22: Hong Kong Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 23: India Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 24: India Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 25: Indonesia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 27: Japan Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 29: Malaysia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 30: New Zealand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 31: Philippines Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 32: Singapore Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 33: South Korea Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 34: Thailand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 35: Vietnam Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 36: Western Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 37: Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 38: Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Western Europe Countries
  • Table 40: Western Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 41: Austria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 42: Belgium Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 43: Denmark Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 44: Finland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 45: France Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 46: France Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 47: Germany Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 48: Germany Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 49: Ireland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 50: Italy Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 51: Netherlands Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 52: Norway Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 53: Portugal Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 54: Spain Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 55: Sweden Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 56: Switzerland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 57: UK Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 58: UK Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 59: Eastern Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 60: Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 61: Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 62: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Table 63: Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 64: Czech Republic Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 65: Poland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 66: Romania Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 67: Russia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 68: Russia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 69: North America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 70: North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 71: North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 72: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, North America Countries
  • Table 73: North America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 74: Canada Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 75: Mexico Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 76: USA Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 77: USA Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 78: South America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 79: South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 80: South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, South America Countries
  • Table 82: South America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 83: Argentina Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 84: Brazil Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 85: Brazil Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 86: Chile Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 87: Colombia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 88: Peru Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 89: Venezuela Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 90: Middle East, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 91: Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 92: Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Middle East Countries
  • Table 94: Middle East Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 95: Saudi Arabia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 96: Israel Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 97: Turkey Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 98: UAE Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 99: Africa, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 100: Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 101: Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 102: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Africa Countries
  • Table 103: Africa Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 104: Egypt Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 105: Nigeria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 106: South Africa Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 107: Johnson & Johnson Financial Performance
  • Table 108: Allergan Plc Financial Performance
  • Table 109: Galderma S.A Financial Performance
  • Table 110: Novartis AG Financial Performance
  • Table 111: GlaxoSmithKline Plc Financial Performance
  • Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 116: Global Dermatology Drugs Market In 2025- Growth Countries
  • Table 117: Global Dermatology Drugs Market In 2025- Growth Segments
  • Table 118: Global Dermatology Drugs Market In 2025- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Dermatology Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 4: Global Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Dermatology Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Dermatology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Dermatology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Dermatology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Dermatology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Global Dermatology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Dermatology Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Figure 12: Per Capita Average Dermatology Drugs Market Expenditure, 2015-2025, Global
  • Figure 13: Asia-Pacific, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Figure 17: Asia-Pacific Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 18: China Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 19: China Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 20: Australia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 21: Australia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 22: Hong Kong Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 23: India Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 24: India Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 25: Indonesia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 26: Indonesia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 27: Japan Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 28: Japan Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 29: Malaysia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 30: New Zealand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 31: Philippines Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 32: Singapore Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 33: South Korea Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 34: Thailand Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 35: Vietnam Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 36: Western Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 38: Western Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Western Europe Countries
  • Figure 40: Western Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 41: Austria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 42: Belgium Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 43: Denmark Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 44: Finland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 45: France Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 46: France Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 47: Germany Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 48: Germany Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 49: Ireland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 50: Italy Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 51: Netherlands Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 52: Norway Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 53: Portugal Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 54: Spain Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 55: Sweden Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 56: Switzerland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 57: UK Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 58: UK Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 59: Eastern Europe, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 60: Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 61: Eastern Europe, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 62: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Figure 63: Eastern Europe Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 64: Czech Republic Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 65: Poland Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 66: Romania Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 67: Russia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 68: Russia Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 69: North America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 70: North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 71: North America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 72: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, North America Countries
  • Figure 73: North America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 74: Canada Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 75: Mexico Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 76: USA Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 77: USA Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 78: South America, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 79: South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 80: South America, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, South America Countries
  • Figure 82: South America Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 83: Argentina Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 84: Brazil Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 85: Brazil Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 86: Chile Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 87: Colombia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 88: Peru Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 89: Venezuela Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 90: Middle East, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 91: Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 92: Middle East, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Middle East Countries
  • Figure 94: Middle East Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 95: Saudi Arabia Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 96: Israel Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 97: Turkey Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 98: UAE Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 99: Africa, Dermatology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 100: Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 101: Africa, Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 102: Per Capita Average Dermatology Drugs Expenditure, 2015-2025, Africa Countries
  • Figure 103: Africa Dermatology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 104: Egypt Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 105: Nigeria Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 106: South Africa Dermatology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 107: Johnson & Johnson Financial Performance
  • Figure 108: Allergan Plc Financial Performance
  • Figure 109: Galderma S.A Financial Performance
  • Figure 110: Novartis AG Financial Performance
  • Figure 111: GlaxoSmithKline Plc Financial Performance
  • Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 116: Global Dermatology Drugs Market In 2025- Growth Countries
  • Figure 117: Global Dermatology Drugs Market In 2025- Growth Segments
  • Figure 118: Global Dermatology Drugs Market In 2025- Growth Strategies
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Inhalation Sedatives Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Insulin Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Skin Cancer Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Anti-Parkinson Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Dermatitis Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Fertility Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
View Report
Cardiovascular Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030
View Report
Antiglaucoma Drugs Market - By Product Type (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others), By Disease Condition Type (Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma), By Prescription Type (OTC Drugs, Prescription Drugs), And By Region, Opportunities And Strategies – Global Antiglaucoma Drugs Market Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)